Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00599014 · ClinicalTrials.gov registry record
Heart Failure Study: The Atlanta Cardiomyopathy Consortium
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 335
- Enrollment target
NCT00599014 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 335 participants.
The verdict
NCT00599014 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 335 participants
- Enrollment target
Study Summary
Heart failure is a very common cause of hospital admission and there are half a million new cases diagnosed each year in the United States. While some important progress has been made over the last two decades for the treatment of heart failure, there still remains a critical need for further advances in our understanding of this disease in order to significantly improve patient outcomes. Large numbers of heart failure patients need to be studied over time to allow scientists to investigate those factors that influence the responses to therapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 335 participants |
| Start Date | 2007-11 |
| Est. Completion | 2013-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00599014
The ClinicalTrials.gov registry entry for NCT00599014 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 335 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00599014 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00599014 about?
NCT00599014 is a clinical study titled "Heart Failure Study: The Atlanta Cardiomyopathy Consortium". Heart failure is a very common cause of hospital admission and there are half a million new cases diagnosed each year in the United States. While some important progress has been made over the last two decades for the treatment of heart failure, there still remains a critical need for further advanc...
What is the current status of trial NCT00599014?
This trial is currently completed. The enrollment target is 335 participants. The study started on 2007-11. Estimated completion is 2013-06.
Who is sponsoring clinical trial NCT00599014?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.